HIT Consultant November 6, 2025
What You Should Know:
– Amae Health, a Public Benefit Corporation (PBC) and leader in outpatient treatment for Severe Mental Illness (SMI), announced the close of a $25M of pre-empted Series B financing led by Altos Ventures.
– The funding brings Amae’s total funding to more than $50M and will accelerate the company’s mission to transform how conditions like schizophrenia, bipolar disorder, and treatment-resistant depression are understood and treated.
Achieving Significant and Sustainable Clinical Outcomes
Traditional treatment models have historically struggled to move the needle for the more than 15 million Americans living with SMI. Amae is pioneering a different path by combining compassionate, in-person, team-based care with responsibly deployed AI.
This integrated approach has achieved striking results...
Today's Sponsors
Today's Sponsor